High-risk follicular lymphomas harbour more somatic mutations including those in the AID-motif-Reference-Cited by-同舟云学术

High-risk follicular lymphomas harbour more somatic mutations including those in the AID-motif

Published:2017-10-25 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Tsukamoto Taku,Nakano Masakazu,Sato Ryuichi,Adachi Hiroko,Kiyota Miki,Kawata Eri,Uoshima Nobuhiko,Yasukawa Satoru,Chinen Yoshiaki,Mizutani Shinsuke,Shimura Yuji,Kobayashi Tsutomu,Horiike Shigeo,Yanagisawa Akio,Taniwaki Masafumi,Tashiro Kei,Kuroda Junya

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-14150-0.pdf

Reference43 articles.

1. Tan, D. et al. Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience. Blood 122, 981–987, https://doi.org/10.1182/blood-2013-03-491514 (2013).

2. Salles, G. et al. Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial. The Lancet 377, 42–51, https://doi.org/10.1016/s0140-6736(10)62175-7 (2011).

3. Hiddemann, W. et al. Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group. Blood 106, 3725–3732, https://doi.org/10.1182/blood-2005-01-0016 (2005).

4. Hiddemann, W. & Cheson, B. D. How we manage follicular lymphoma. Leukemia 28, 1388–1395, https://doi.org/10.1038/leu.2014.91 (2014).

5. Link, B. K. et al. Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa/MayoClinic Specialized Program of Research Excellence Molecular Epidemiology Resource. J Clin Oncol 31, 3272–3278, https://doi.org/10.1200/JCO.2012.48.3990 (2013).

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironments;Cell Reports Medicine;2024-03

2. AID in non-Hodgkin B-cell lymphomas: The consequences of on- and off-target activity;Advances in Immunology;2024

3. Noncoding mutations cause super-enhancer retargeting resulting in protein synthesis dysregulation during B cell lymphoma progression;Nature Genetics;2023-12

4. Associations between Smoking and Alcohol and Follicular Lymphoma Incidence and Survival: A Family-Based Case-Control Study in Australia;Cancers;2022-05-30

5. Distinct clinical and genetic features of hepatitis B virus–associated follicular lymphoma in Chinese patients;Blood Advances;2022-04-29